REFR 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-06

• The Company’s fee income from licensing activities for the three months ended June 30, 2026 was $86,346 as compared to $129,904 for the three months ended June 30, 2025. This decrease in fee income was primarily the result of non-recurring royalties from a licensee that ceased operations after the s…

• Operating expenses decreased by $148,706 for the three months ended June 30, 2026 to $627,216 from $775,922 for the three months ended June 30, 2025. This decrease is the result of lower employee compensation ($111,000) and directors fees and expenses ($107,000), as well as lower marketing and inves…

• As a consequence of the factors discussed above, the Company’s net loss was $660,168 ($0.02 per common share) for the three months ended June 30, 2026 as compared to net loss of $803,826 ($0.02 per common share) for the three months ended June 30, 2025.

• Six months ended June 30, 2026 compared to the six months ended June 30, 2025

• The Company’s fee income from licensing activities for the six months ended June 30, 2026 was $222,665 as compared to $689,680 for the six months ended June 30, 2025. This decrease in fee income was primarily the result of royalties and upfront fees recognized by the Company under ASC 606 revenue tr…

相对上期删除的文字 · 来源:10-Q · 2026-05-08

• The Company’s fee income from licensing activities for the three months ended March 31, 2026 was $136,319 as compared to $559,776 for the three months ended March 31, 2025. This decrease in fee income was primarily the result of royalties and upfront fees recognized by the Company under ASC 606 reve…

• Operating expenses decreased by $115,094 for the three months ended March 31, 2026 to $521,382 from $636,476 for the three months ended March 31, 2025. This decrease is primarily the result of lower directors fees ($120,000).

• The Company recorded $47,357 of other income for the three months ended March 31, 2025 relating to an Employee Retention Credit, a refundable tax credit available under the CARES Act that was designed to keep employees on the payroll during the Covid-19 pandemic.

• As a consequence of the factors discussed above, the Company’s net loss was $525,365 ($0.02 per common share) for the three months ended March 31, 2026 as compared to net loss of $177,687 ($0.01 per common share) for the three months ended March 31, 2025.

• During the three months ended March 31, 2026, the Company’s cash and cash equivalents balance increased by $615,002 as a result of cash received from the sale of common stock and warrants of $1,375,000 partially offset by used to fund operations of $759,931 and cash used to purchase fixed assets of …